Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.
A 400-mg dose of the trifluorinated quinolone Ro 23-6240 was administered orally to each of six healthy male volunteers, after which the concentrations of this agent in serum and cantharidin-induced inflammatory fluid were measured. Absorption was rapid, with a mean peak level in serum of 6.1 micrograms/ml, which was attained 0.71 h after administration. The elimination half-life in serum was 11.95 h. The agent penetrated the inflammatory fluid rapidly; the percent penetration was 89.7%. Urinary recovery of Ro 23-6240 was 58.6% by 72 h.
D000284:Administration, Oral; D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000378:metabolism*; D001768:Blister / Q000378:metabolism; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism; D005122:Exudates and Transudates / Q000378:metabolism; D016576:Fleroxacin; D006801:Humans; D007700:Kinetics; D008297:Male
D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D016576:Fleroxacin